Poehling Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Sell |
2,728
-5
| -0.2% | -$415 | 0.05% | 125 |
|
|
2025
Q1 | $222K | Sell |
2,733
-96
| -3% | -$7.79K | 0.06% | 125 |
|
|
2024
Q4 | $255K | Buy |
2,829
+69
| +3% | +$6.21K | 0.06% | 123 |
|
|
2024
Q3 | $273K | Sell |
2,760
-215
| -7% | -$21.2K | 0.07% | 118 |
|
|
2024
Q2 | $276K | Sell |
2,975
-6
| -0.2% | -$556 | 0.08% | 119 |
|
|
2024
Q1 | $283K | Sell |
2,981
-15
| -0.5% | -$1.42K | 0.08% | 112 |
|
|
2023
Q4 | $268K | Sell |
2,996
-10
| -0.3% | -$893 | 0.08% | 109 |
|
|
2023
Q3 | $219K | Sell |
3,006
-62
| -2% | -$4.53K | 0.08% | 113 |
|
|
2023
Q2 | $255K | Hold |
3,068
| – | – | 0.09% | 109 |
|
|
2023
Q1 | $234K | Sell |
3,068
-2
| -0.1% | -$152 | 0.08% | 108 |
|
|
2022
Q4 | $255K | Sell |
3,070
-502
| -14% | -$41.7K | 0.1% | 103 |
|
|
2022
Q3 | $283K | Sell |
3,572
-8
| -0.2% | -$634 | 0.12% | 88 |
|
|
2022
Q2 | $266K | Sell |
3,580
-6,559
| -65% | -$487K | 0.1% | 100 |
|
|
2022
Q1 | $911K | Buy |
10,139
+5,438
| +116% | +$489K | 0.28% | 77 |
|
|
2021
Q4 | $526K | Buy |
+4,701
| New | +$526K | 0.17% | 88 |
|
|
2018
Q3 | – | Sell |
-75
| Closed | -$7K | – | 264 |
|
|
2018
Q2 | $7K | Hold |
75
| – | – | 0.01% | 246 |
|
|
2018
Q1 | $7K | Hold |
75
| – | – | 0.01% | 255 |
|
|
2017
Q4 | $6K | Buy |
+75
| New | +$6K | 0.01% | 233 |
|